Wednesday, October 20, 2021 – CHIPTS and our partners at Stanford University hosted an in-person/virtual (hybrid) symposium entitled “HIV, Methamphetamine Use, and Pulmonary Hypertension: From Blue Skies to an Integrated Research Agenda.” Chronic methamphetamine use with concomitant HIV infection is thought to act synergistically to fuel both the development and progression of pulmonary arterial hypertension (PAH) – resulting in more rapid progression of disease and poorer outcomes among methamphetamine-using individuals living with HIV. However, the impacts of chronic methamphetamine use and HIV infection in relation to the diagnosis and clinical trajectory of PAH are not fully understood. Dr. Cherie S. Blair led this day-long, multidisciplinary “think tank” meeting of investigators from institutions across the US to discuss the development of an integrated research agenda to address HIV, methamphetamine use, and pulmonary hypertension.

The objectives of the symposium were to:

  • Share the latest research findings and current state of knowledge surrounding HIV, methamphetamine use, and pulmonary hypertension.
  • Define the behavioral research agenda for HIV, methamphetamine use, and pulmonary hypertension.
  • Identify cross-disciplinary intersections to yield funded research on HIV, methamphetamine use, and pulmonary hypertension.

An expert panel of speakers were featured at the symposium, including:

  • Stuti Agarwal, PhD (Stanford University)
  • Jennifer Fulcher, MD, PhD (UCLA)
  • Michael Li, PhD (UCLA)
  • Vinicio de Jesus Perez, MD (Stanford University)
  • Steve Shoptaw, PhD (UCLA)
  • Madhukar Trivedi, MD (University of Texas Southwestern)
  • Roham Zamanian, MD (Stanford University)

Please see the symposium flyer and recordings below. If you have any questions, please contact Cheríe Blair, MD, PhD, Assistant Clinical Professor in the UCLA Department of Medicine, at CherieBlair@mednet.ucla.edu.

Flyer: HIV, Methamphetamine Use, and Pulmonary Hypertension: From Blue Skies to an Integrated Research Agenda Agenda: HIV, Methamphetamine Use, and Pulmonary Hypertension: From Blue Skies to an Integrated Research Agenda

Agenda:

Event Recording:

Presentation Title: “Epidemiology of Methamphetamine Use and Infectious Diseases: Methamphetamine Use and Outcomes Along ART and CTRA Gene Expression”

Presenter: Michael Li, PhD (UCLA)

 

Presentation Title: “Pathophysiology and Clinical Outcomes of Pulmonary Hypertension Identifying Points for Prevention and Intervention”

Presenters: Vinicio de Jesus Perez, MD and Roham Zamanian, MD

 

Presentation Title: “Contributions of HIV and Methamphetamine Use to Pulmonary Hypertension Current State of What is Known”

Presenter: Stuti Agarwal, PhD (Stanford University)

 

Presentation Title: “Neuropsychiatric Complications Linked with Methamphetamine Use, Addiction and Cardiovascular Disease”

Presenter: Madhukar Trivedi, MD (University of Texas Southwestern)

 

Presentation Title: “Overview of Treatments for Methamphetamine Use Disorder”

Presenter: Steve Shoptaw, PhD (UCLA)

 

Presentation Title: “Pathophysiology and Mechanisms of Inflammation with Methamphetamine Use”

Presenter: Jennifer Fulcher, MD, PhD